Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to  develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.

View Full Article